#CROI2024
LightNews LightNews
matthewhodson.bsky.social
Some babies, who acquired HIV in utero and received treatment within 2 days of birth, seem able to control their HIV without treatment - a functional cure.
#CROI2024
www.aidsmap.com/news/mar-202...
Some children who start antiretrovirals very early may control HIV after stopping treatment
A small proportion of children who start HIV treatment within the first two days of life may achieve ongoing viral suppression after stopping antiretrovirals, according to study results presented yest...
www.aidsmap.com
March 8, 2024 at 8:14 AM
matthewhodson.bsky.social
Hopes for an effective combo approach against gonorrhoea with a vaccine/PEP (DoxyPEP) are dashed as study reports.
#CROI2024
www.aidsmap.com/news/mar-202...
Full analysis of French STI study dashes hopes for a gonorrhoea vaccine
A year ago, the DoxyVAC study’s interim results raised hopes that by combining post-exposure prophylaxis using the antibiotic doxycycline (‘doxyPEP’) with a candidate vaccine against gonorrhoea, cases...
www.aidsmap.com
March 5, 2024 at 10:17 AM
matthewhodson.bsky.social
Is HIV starting to develop resistance to dolutegravir - one of the most widely used antiretrovirals in the world?
An aidsmap report on findings from #CROI2024.
www.aidsmap.com/news/mar-202...
The cornerstone of HIV treatment may be losing some of its power: will dolutegravir resistance become a problem?
A number of presentations at last week’s Conference on Retroviruses and Opportunistic Infections (CROI 2024) looked at whether HIV is starting to develop resistance to dolutegravir, one of the mo...
www.aidsmap.com
March 15, 2024 at 9:33 AM
scibri.com
New data presented at #CROI2024 shows that giving people doxycycline after risky sex helped cut rates of STIs in half in San Francisco among gay men and transgender women. My story for Medscape. 🧪 IDSky
www.medscape.com/viewarticle/...
Doxy-PEP Cut STIs in San Francisco in Half
Postexposure prophylaxis with doxycycline reduced some sexually transmitted infection rates in half in certain populations but concerns about antibiotic resistance remain.
www.medscape.com
March 5, 2024 at 11:26 PM
matthewhodson.bsky.social
New drug formulation for 3 injections per year, could make HIV treatment or PrEP simpler and easier to stick with.
#CROI2024
www.aidsmap.com/news/mar-202...
Ultra-long-acting cabotegravir could be taken three times a year for HIV PrEP and treatment
A longer-acting formulation of cabotegravir may offer an HIV pre-exposure prophylaxis (PrEP) and treatment option that could be administered once every four months, according to early study resul...
www.aidsmap.com
March 13, 2024 at 8:42 AM
matthewhodson.bsky.social
In 2022, San Francisco became the 1st city to recommend #DoxyPEP for gay and bi men and trans people.
The impact is already being seen - with drops in chlamydia and syphilis.
#CROI2024
www.aidsmap.com/news/mar-202...
Sexually transmitted infections in San Francisco have fallen since doxyPEP roll-out
Taking the antibiotic doxycycline after sex appears to have lowered the incidence of sexually transmitted infections (STIs) in San Francisco, according to researchers who presented some of the earlies...
www.aidsmap.com
March 6, 2024 at 8:32 AM
lizhighleyman.bsky.social
News from #CROI2024: Deborah Persaud reports that among 54 children born with #HIV & treated within 48 hours, 6 met strict eligibility criteria for analytic treatment interruption & 4 had sustained remission for at least a year.
www.poz.com/article/chil...
Some Children Treated Very Early Have Sustained HIV Remission
Four of six children treated within 48 hours after birth maintained viral suppression for at least a year after stopping therapy.
www.poz.com
March 7, 2024 at 8:52 PM
matthewhodson.bsky.social
Promising results suggest once a week doses on the way for HIV treatment.
#CROI2024
www.aidsmap.com/news/mar-202...
Once-weekly antiretrovirals on the horizon
Two antiretrovirals with the potential for once-weekly oral dosing were unveiled at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) in Denver on Monday.
www.aidsmap.com
March 7, 2024 at 2:22 PM
matthewhodson.bsky.social
US men with prostate cancer (on course to be the most diagnosed cancer for people with HIV by the end of this decade) are more likely to be diagnosed late if they also have HIV.
#CROI2024
www.aidsmap.com/news/mar-202...
Prostate cancer diagnosed later in US men with HIV
Men with HIV in the US’s largest care provider for people with HIV were more likely to be diagnosed late with prostate cancer and less likely to undergo testing that may warn of an increased prostate ...
www.aidsmap.com
March 9, 2024 at 10:45 AM
lizhighleyman.bsky.social
News from #CROI2024: Clinical practice & population-level analyses from SF are consistent with clinical trial findings, showing #doxyPEP reduces chlamydia & syphilis, but less so gonorrhea.
www.aidsmap.com/news/mar-202...
Sexually transmitted infections in San Francisco have fallen since doxyPEP roll-out
Taking the antibiotic doxycycline after sex appears to have lowered the incidence of sexually transmitted infections (STIs) in San Francisco, according to researchers who presented some of the earlies...
www.aidsmap.com
March 5, 2024 at 11:17 AM
crankyqueer.bsky.social
"Clotting is essential in the pathogenesis of #SARS-CoV-2, and that's because one of the host defenses against #SARS-CoV-2 is strong inflammation." Roger Paredes #CROI2024 #LongCOVID
Model of thromboinflammation that shows differences between normal platelet response and COVID-19 thrombocytopathy
March 12, 2025 at 4:09 PM
matthewhodson.bsky.social
#PrEP for young women 6-nation African study finds high take up, good adherence and multiple emotional health benefits.
#CROI2024
www.aidsmap.com/news/mar-202...
Six-country African PrEP study achieves high levels of persistence and good adherence in young women
A demonstration project of oral PrEP for young women, conducted in six African countries with high HIV prevalence, achieved high levels of PrEP uptake and persistence, and good levels of adherence amo...
www.aidsmap.com
March 10, 2024 at 11:30 AM
deutscheaidshilfe.bsky.social
Die Ergebnisse der ersten kontrollierten Studie zu diesem Thema, die ACTG-Studie LATITUD (Long-Acting Therapy to Improve Treatment Success in Daily Life), soll auf der CROI2024 präsentiert werden. (2)
March 5, 2024 at 2:59 PM
lizhighleyman.bsky.social
News from #CROI2024: Cabenuva for people without viral suppression & long-acting cabotegravir + lenacapavir may be options for people with #HIV who can’t take daily pills.
www.poz.com/article/inno...
Innovative Use of Long-Acting Injectables Holds Promise for People with Adherence Challenges
Cabenuva for people without viral suppression and cabotegravir plus lenacapavir may be options for those who can’t take daily pills.
www.poz.com
March 20, 2024 at 7:52 PM
scibri.com
Syphilis has come roaring back in recent years, and many of today's physicians lack experience with diagnosing and treating it. My story for Medscape #CROI2024 🧪 IDsky
www.medscape.com/viewarticle/...
Inexperience Diagnosing Syphilis Adding to Higher Rates
After years of not seeing any cases of syphilis, rising rates mean that clinicians are having to refresh their diagnostic and treatment skills for the sexually transmitted infection.
www.medscape.com
March 14, 2024 at 12:39 PM
matthewhodson.bsky.social
The wide disparities in access to PrEP between US States is reflected in the rate of decrease (or not) of new HIV diagnoses.
PrEP works - remove barriers to access.
aidsmap report on new data from CROI2024
www.aidsmap.com/news/mar-202...
Blue pill with PrEP works written on it.
March 6, 2024 at 10:26 AM
matthewhodson.bsky.social
Offering choice (inc. injectable) and flexibility massively increases PrEP uptake.
Results from trial in rural Kenya and Uganda presented at #CROI2024.
www.aidsmap.com/news/mar-202...
Huge increase in PrEP uptake when services offer choice, flexibility <i>and</i> injectable PrEP, African study shows
A programme in rural Kenya and Uganda that has already demonstrated that a dynamic, person-centred HIV prevention intervention results in substantial increases in the numbers of people covered by PrEP...
www.aidsmap.com
March 12, 2024 at 7:39 AM
lizhighleyman.bsky.social
News from #CROI2024. More evidence for the benefits of starting #HIV treatment ASAP after diagnosis.

Delayed HIV Treatment Raises Risk of Complications and Death Years Later
www.poz.com/article/dela...
Delayed HIV Treatment Raises Risk of Complications and Death Years Later
Inflammation before initiation of antiretroviral therapy can have long-term consequences, including AIDS, cardiovascular disease and death.
www.poz.com
March 27, 2024 at 9:30 PM
drdavidwjg.bsky.social
100%

There was some really interesting data presented at #CROI2024 which explored racial disparities in the lifetime risk of acquiring HIV and highlighted some of those issues of intersectionality.

www.aidsmap.com/news/mar-202...

#HIVsky #IDsky
Progress in reducing new HIV diagnoses much slower for Black men in the US
Lifetime risk of acquiring HIV has decreased for Black gay and bisexual men in the US, from 1 in 2 from 2010 to 2014 to 1 in 3 from 2017 to 2021, according to data presented to the Conference on Retro...
www.aidsmap.com
November 24, 2024 at 12:04 AM
matthewhodson.bsky.social
Australian gay and bi men who continued with #PrEP enjoyed a 79% reduction in HIV diagnoses compared to those who only filled their prescription once.
#CROI2024
www.aidsmap.com/news/mar-202...
Far fewer HIV infections in Australian PrEP users – consistent use is key
An impressive 79% reduction in HIV incidence was seen between two directly comparable groups in a whole-population analysis from Australia, presented to the Conference on Retroviruses and Opportunisti...
www.aidsmap.com
March 11, 2024 at 10:21 AM
dtcitron.bsky.social
So exciting to be here at #croi #croi2024, presenting our team's simulation model of the co-dynamics between HIV and depression and how each of these conditions makes the other worse.
March 6, 2024 at 11:26 PM